← Leaderboards
Jason Jones
Dropletpharm Inc.
$1,262,509
Attributed
$2,111,788
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $837.9K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$2,111,788 · 4
By mechanism
R01$1,273,918 · 1
R41$562,104 · 2
R43$275,766 · 1
Top collaborators
- Kai Chen2 shared
- Robert Michael Van Dam2 shared
Others in their field
Other Rising Stars on “Cost”
- Katherine M Thibault · Battelle Memorial Institute$134,148,552
- Richard Smith · Medical Device Innovation Consortium$41,401,350
- Thierry Diagana · University Of Texas Med Br Galveston$37,506,320
- Julia Louise Moore Vogel · Scripps Research Institute, The$32,252,685
- Tim A Bertram · Wake Forest University School Of Medicine$30,163,580
- Supriya Menezes · The Emmes Company, Llc$25,277,032
Research focus
CostTracerIsotopesReagentCellsTechnologyPositron-Emission TomographyRadiochemistryProductionDoseMonitorManufacturePerformanceClinical ResearchClinical TrialsImageFutureReactionCyclic GmpEnsureCommercializationInterestClinical TranslationAmendment
Grant awards (5)
Enabling translation of cancer cell proliferation PET imaging via droplet radiochemistry technology$617,737
R01 · FY2025 · CA
Enabling translation of cancer cell proliferation PET imaging via droplet radiochemistry technology$656,181
R01 · FY2024 · CA
Demonstrating miniaturized production of a KOR PET tracer as a proof-of-concept for low-cost distribution of nascent PET neurotracers$286,331
R41 · FY2023 · DA · contact PI
Production of radiometal-based radiopharmaceuticals at a clinical scale via droplet-scale radiochemistry$275,773
R41 · FY2023 · EB · contact PI
Microchip electrophoresis as basis for fully integrated, fully automated, low-cost radiopharmaceutical QC platform$275,766
R43 · FY2023 · CA · contact PI